Beyond market averages, investors looking for exceptional returns turn to stock picking. Skillful choices in individual stocks have the power to substantially increase your wealth.
The closing price of Molina Healthcare Inc (NYSE: MOH) was $160.28 for the day, down -1.57% from the previous closing price of $162.84. In other words, the price has decreased by -$1.57 from its previous closing price. On the day, 1.78 million shares were traded. MOH stock price reached its highest trading level at $164.91 during the session, while it also had its lowest trading level at $160.0.
Ratios:
Our analysis of MOH’s different ratios will help us gain a deeper understanding of the company. In the meantime, Its Debt-to-Equity ratio is 0.92 whereas as Long-Term Debt/Eq ratio is at 0.92.
On October 16, 2025, TD Cowen Downgraded its rating to Hold which previously was Buy but kept the price unchanged to $203.
On October 14, 2025, Goldman started tracking the stock assigning a Neutral rating and target price of $207.Goldman initiated its Neutral rating on October 14, 2025, with a $207 target price.
Insider Transactions:
Also, insider trades can serve as a great indicator of what management thinks about the future direction of a stock’s price. A recent insider transaction in this stock occurred on Aug 06 ’25 when ROMNEY RONNA sold 700 shares for $153.74 per share. The transaction valued at 107,618 led to the insider holds 17,131 shares of the business.
WOYS JAMES bought 10,000 shares of MOH for $1,559,365 on Aug 04 ’25. The Chief Operating Officer now owns 74,331 shares after completing the transaction at $155.94 per share. On Aug 04 ’25, another insider, ROMNEY RONNA, who serves as the Director of the company, bought 700 shares for $157.99 each.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, MOH now has a Market Capitalization of 8238391808 and an Enterprise Value of 3643392000. As of this moment, Molina’s Price-to-Earnings (P/E) ratio for their current fiscal year is 9.93, and their Forward P/E ratio for the next fiscal year is 10.35. For the stock, the TTM Price-to-Sale (P/S) ratio is 0.18 while its Price-to-Book (P/B) ratio in mrq is 1.95. Its current Enterprise Value per Revenue stands at 0.085 whereas that against EBITDA is 2.501.
Stock Price History:
The Beta on a monthly basis for MOH is 0.54, which has changed by -0.50102735 over the last 52 weeks, in comparison to a change of 0.20772064 over the same period for the S&P500. Over the past 52 weeks, MOH has reached a high of $359.97, while it has fallen to a 52-week low of $151.95. The 50-Day Moving Average of the stock is -12.61%, while the 200-Day Moving Average is calculated to be -37.48%.
Shares Statistics:
MOH traded an average of 1.50M shares per day over the past three months and 2409270 shares per day over the past ten days. A total of 51.00M shares are outstanding, with a floating share count of 50.83M. Insiders hold about 1.11% of the company’s shares, while institutions hold 105.83% stake in the company. Shares short for MOH as of 1760486400 were 3221202 with a Short Ratio of 2.15, compared to 1757894400 on 3061574. Therefore, it implies a Short% of Shares Outstanding of 3221202 and a Short% of Float of 8.430000399999999.
Earnings Estimates
The firm’s stock currently is rated by 14.0 analysts. The consensus estimate for the next quarter is $4.78, with high estimates of $6.58 and low estimates of $2.7.
Analysts are recommending an EPS of between $18.92 and $13.26 for the fiscal current year, implying an average EPS of $15.12. EPS for the following year is $15.4, with 17.0 analysts recommending between $21.09 and $11.0.
Revenue Estimates
It is expected that $90B in revenue will be generated in. The current quarter, according to 12 analysts. It ranges from a high estimate of $11.29B to a low estimate of $10.46B. As of. The current estimate, Molina Healthcare Inc’s year-ago sales were $10.5BFor the next quarter, 12 analysts are estimating revenue of $11.56B. There is a high estimate of $12.05B for the next quarter, whereas the lowest estimate is $11.16B.
A total of 13 analysts have provided revenue estimates for MOH’s current fiscal year. The highest revenue estimate was $45.34B, while the lowest revenue estimate was $44.12B, resulting in an average revenue estimate of $44.79B. In the same quarter a year ago, actual revenue was $40.65BBased on 10 analysts’ estimates, the company’s revenue will be $46.9B in the next fiscal year. The high estimate is $47.71B and the low estimate is $44.85B.
